These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 779590

  • 1. Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
    Hartikainen M, Heikkilä J.
    Ann Clin Res; 1976 Apr; 8(2):85-92. PubMed ID: 779590
    [Abstract] [Full Text] [Related]

  • 2. A comparison between metoprolol and pindolol in the treatment of essential hypertension.
    Tuomilehto J, Pohjola M.
    Ann Clin Res; 1978 Feb; 10(1):24-9. PubMed ID: 28070
    [Abstract] [Full Text] [Related]

  • 3. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.
    Potempa KM, Fogg LF, Fish AF, Kravitz HM.
    Heart Lung; 1993 Feb; 22(5):383-91. PubMed ID: 8226001
    [Abstract] [Full Text] [Related]

  • 4. [Antihypertensive therapy with a new beta-blocking agent Timolol. Double blind study and comparison with Alprenolol and Pindolol (author's transl)].
    Wessels F, Heinze A, Werth HW.
    Med Klin; 1977 Oct 14; 72(41):1689-95. PubMed ID: 335203
    [Abstract] [Full Text] [Related]

  • 5. Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension.
    Dahlöf B, Andrén L, Eggertsen R, Jern S, Svensson A, Sievert A, Aurell M, Hansson L.
    J Cardiovasc Pharmacol; 1987 Oct 14; 10 Suppl 10():S102-4. PubMed ID: 2455104
    [Abstract] [Full Text] [Related]

  • 6. Comparison of ketanserin and pindolol in hypertension.
    Gordin A, Saraste K, Turanlahti M, Sundberg S.
    J Hypertens Suppl; 1986 Apr 14; 4(1):S61-2. PubMed ID: 2939214
    [Abstract] [Full Text] [Related]

  • 7. Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension.
    Chalmers JP, Korner PI, Tiller DJ, Bune AJ, Steiner JD, West MJ, Wing LM, Uther JF.
    Med J Aust; 1976 May 01; 1(18):650-3. PubMed ID: 781495
    [Abstract] [Full Text] [Related]

  • 8. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
    Himori N, Ishimori T, Izumi A, Hiramatsu Y.
    Arch Int Pharmacodyn Ther; 1977 Jan 01; 225(1):152-65. PubMed ID: 15525
    [Abstract] [Full Text] [Related]

  • 9. [The combination of methyldopa with pindolol in the treatment of hypertension (author's transl)].
    Szám I, Pálossy B.
    MMW Munch Med Wochenschr; 1978 Dec 23; 120(51-52):1719-22. PubMed ID: 105251
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan 23; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive effect of bopindolol: a multi-centre study.
    Török E, Szám I, Buday G, Kerkovits G, Farsang C, Hajtman B.
    J Hum Hypertens; 1990 Aug 23; 4(4):458-60. PubMed ID: 1979635
    [Abstract] [Full Text] [Related]

  • 12. Comparisons of verapamil administration twice and three times daily in hypertension.
    Salmela PI, Gordin A, Salo H, Ottoila P, Jounela AJ.
    Ann Clin Res; 1988 Aug 23; 20(3):195-200. PubMed ID: 3058014
    [Abstract] [Full Text] [Related]

  • 13. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD, Binstok G, Mullane JF, Woods JW, Pittman AW, del Greco F, Huang C, Morledge JH.
    Clin Ther; 1983 Aug 23; 5(5):525-39. PubMed ID: 6352036
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L, Hiremath, Kerkar PG, Manade VG.
    J Assoc Physicians India; 2004 Mar 23; 52():197-202. PubMed ID: 15636308
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
    Velasco M, Morillo J, Urbina A, Kögler P, Leishman B, Pasquier M, Hernändez-Pieretti O.
    Int J Clin Pharmacol Res; 1987 Mar 23; 7(6):443-54. PubMed ID: 3440635
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of pindolol dosage in hypertension by automatic indirect BP monitoring.
    Sheps SG, Schirger A, Spiekerman RE, Harman TR, O'Brien PC, Kleven MK, Kremer-Simpson K.
    Arch Intern Med; 1985 Jan 23; 145(1):54-7. PubMed ID: 3970647
    [Abstract] [Full Text] [Related]

  • 18. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O, Rydén L.
    Acta Med Scand; 1981 Jan 23; 209(4):261-6. PubMed ID: 7015797
    [Abstract] [Full Text] [Related]

  • 19. [Combined treatment with beta-receptor blocker pindolol and diureticum trichlormethiazidum in patients with essential hypertony in stadium II WHO (author's transl))].
    Zdichynec B.
    Z Kardiol; 1977 Sep 23; 66(9):508-10. PubMed ID: 335687
    [Abstract] [Full Text] [Related]

  • 20. [Blood pressure and renin activity in essential hypertension under pindolol].
    Nussberger J, Vetter W, Furrer J, Beckerhoff R, Würsten D, Schmied U, Siegenthaler W.
    Schweiz Med Wochenschr; 1976 Jun 12; 106(24):831-4. PubMed ID: 996500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.